Eli Lilly is coming after makers of copycat versions of Zepbound
Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound.Read more...
Eli Lilly is stepping up its fight against copycat weight-loss drugs
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/5bc77f386d5c6e836ccdfd706685736c.jpg"/><p>In its continuing war against copyca [...]
Eli Lilly's online health platform just expanded beyond weight loss to
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e4b70d65bbdfcb4854862d2a597ad777.jpg"/><p>Just about a year after launching a [...]
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/c45b4d7b37b7f8cb4e6dd83e52b76b28.jpg"/><p>An Eli Lilly exec said the company†[...]